1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. MAZE THERAPEUTICS INC.

Maze Therapeutics Inc.

XNAS: MAZE

Download real time

12.59 1.60 (14.56%)

New 52W Low today

51,112 XNAS Volume

XNAS 17 Mar, 2025 1:05 PM (EDT)

Watchlist

Portfolio

Share
8S
5W
1O
0T
551.2

Market Cap

Below industry Median
-

PE TTM

-

PEG TTM

-1.9

Price to Book

Negative Price to Book
-

Beta 1Year



Insider Trading disclosures for Maze Therapeutics Inc.

The latest disclosure was made by Charles J. Homcy in Maze Therapeutics Inc. where a trade of 169,405 Series C Preferred Stock done was reported to US exchanges on Feb. 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Charles J. Homcy Director 03 Feb 2025 169,405 0 - - Series C Preferred Stock
Jonathan E. Lim Director 03 Feb 2025 37,724 37,724 - - Common Stock
Jonathan E. Lim Director 03 Feb 2025 363,703 0 - - Series A Preferred Stock
Jonathan E. Lim Director 03 Feb 2025 2,231,381 0 - - Series B Preferred Stock
Jonathan E. Lim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 5,704 5,704 - - Stock Option (Right to Buy)
Jonathan E. Lim Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 5,704 0 - - Stock Option (Right to Buy)
Jonathan E. Lim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 9,086 9,086 - - Stock Option (Right to Buy)
Jonathan E. Lim Director 03 Feb 2025 270,232 307,956 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 20,717 58,047 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 7,422 7,422 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 72,727 0 - - Series B Preferred Stock
Charles J. Homcy Director 03 Feb 2025 8,807 37,330 - - Common Stock
Charles J. Homcy Director 03 Feb 2025 71,564 0 - - Series D-1 Preferred Stock
Charles J. Homcy Director 03 Feb 2025 71,564 7,422 - - Series D-1 Preferred Stock
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 80,385 80,385 - - Stock Option (Right to Buy)
Charles J. Homcy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 80,385 0 - - Stock Option (Right to Buy)
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 5,704 5,704 - - Stock Option (Right to Buy)
Charles J. Homcy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 5,704 0 - - Stock Option (Right to Buy)
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 46,675 46,675 - - Stock Option (Right to Buy)
Charles J. Homcy Director Sale or transfer of securities back to the company at price $ 0.00 per share. 03 Feb 2025 46,675 0 - - Stock Option (Right to Buy)
Charles J. Homcy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Feb 2025 45,638 45,638 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters